Navigation Links
AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2012 Financial Results
Date:3/12/2013

REDWOOD CITY, Calif., March 12, 2013 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ("AcelRx"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today reported financial results for the fourth quarter and year ended December 31, 2012, and provided a corporate update.

(Logo: http://photos.prnewswire.com/prnh/20130226/MM67303LOGO)

"We made important strides in the advancement of our sublingual Sufentanil NanoTab PCA System for the management of moderate to severe post-operative pain in 2012 and early 2013.  We announced positive results from two completed Phase 3 clinical trials, and we expect the results from our third and final planned Phase 3 trial of the NanoTab System in the second quarter of 2013," stated Richard King , President and CEO of AcelRx. Mr. King added, "In addition, in December 2012, we strengthened our balance sheet when we raised $48 million in gross proceeds, $44 million in net proceeds, through a public offering of our common stock. These funds will provide the capital needed to submit an NDA for the NanoTab System, expected in the third quarter of 2013, and to continue with commercial preparations for launch of the product in the U.S."

Fourth Quarter and Full Year Financial ResultsNet loss for the fourth quarter of 2012 was $10.5 million, or $0.41 per share, compared with a net loss of $6.4 million, or $0.33 per share, for the fourth quarter of 2011.  Common shares used in calculating basic and diluted earnings per share were 25,587,614 for the fourth quarter of 2012 compared to 19,567,778 common shares for the fourth quarter of 2011.

During the fourth quarter of 2012, Acel
'/>"/>

SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. AcelRx Pharmaceuticals to Hold Fourth Quarter 2012 Financial Results Conference Call and Webcast on March 12, 2013
2. AcelRx Top-line Data Show Primary Endpoint Achieved in Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Post-Operative Pain in Major Open Abdominal Surgery Patients
3. AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences
4. AcelRx Pharmaceuticals Provides Clinical Trial Updates
5. AcelRx Appoints Adrian Adams to Board of Directors as Chairman
6. AcelRx Pharmaceuticals Announces Pricing of Public Offering of Common Stock
7. AcelRx Pharmaceuticals Announces Proposed Public Offering Of Common Stock
8. AcelRx Pharmaceuticals to Present at the Piper Jaffray 24th Annual Healthcare Conference
9. AcelRx Announces Achievement of the Primary End-Point in Phase 3 Comparative Study Involving the Sufentanil NanoTab PCA System and Plans to Hold a Conference Call and Webcast Tomorrow to Discuss Top-Line Results
10. AcelRx Pharmaceuticals Reports Third Quarter 2012 Financial Results
11. AcelRx Pharmaceuticals Doses the First Patients in ARX-04 Phase 2 Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... -- Indianapolis interventional medical device maker NICO Corporation ... visualization leader Synaptive Medical announced today ... that they have joined forces to integrate their ... the first of its kind and will make ... BrainPath® interventional access technology and Synaptive,s BrightMatter™ real-time ...
(Date:10/20/2014)... 20, 2014 Valeritas, Inc., a leader in ... with Type 2 diabetes, announced today that it has ... The award was presented October 16 th at ... Ohio . The Cardinal Health ... variety of metrics specifically targeted at the importance of ...
(Date:10/20/2014)... PRINCETON, N.J. , Oct. 20, 2014 /PRNewswire/ ... Taiho Pharmaceutical Co., Ltd. ( Japan ... Administration (FDA) granted Fast Track designation for TAS-102 ... combination anticancer drug under investigation for the treatment ... the Company has initiated a rolling NDA submission ...
Breaking Medicine Technology:Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 2Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 3Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 4Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 5Valeritas Receives 2014 Cardinal Health Supply Chain Excellence Award 2Valeritas Receives 2014 Cardinal Health Supply Chain Excellence Award 3Taiho Oncology, Inc. Receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer 2Taiho Oncology, Inc. Receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer 3Taiho Oncology, Inc. Receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer 4
... PHILADELPHIA, Sept. 15 Asthma researchers,have found that a ... asthma,in European children plays a similar role in white ... most common chronic illness among children in the developed ... of genes are thought to,interact with each other and ...
... Clinical Psychopharmacology ... Meeting, WELLESLEY ... the assets of Spherics, Inc. ("Spherics") for,the benefit of creditors, announced today ... bid auction on October 10,2008., Topamax(R) produces adverse effects on cognitive ...
Cached Medicine Technology:More Findings on Gene Involved in Childhood Asthma 2More Findings on Gene Involved in Childhood Asthma 3Spherics, Inc. Announces Reduced Cognitive Impairment of Novel Extended Release Topiramate (SRx-502) as Compared to Topamax(R) 2
(Date:10/20/2014)... Oregon (PRWEB) October 20, 2014 Succeed is ... of local companies who participated in the Every Body ... is a public awareness project that encourages workers to be ... Summer Step 10,000 Program, which concluded at the end of ... variety of cities and metro areas. Participating companies gave ...
(Date:10/20/2014)... DALLAS (PRWEB) October 20, 2014 It’s hard ... for many orphans and vulnerable children around the world, it’s ... by some people, many children are forced to walk barefoot ... for their families or play with their friends. , ... partnering with Air1 Radio in October to encourage ...
(Date:10/19/2014)... The leading review website, Top10BestSEOHosting.com, has recently ... are the best Dedicated Server Hosting suppliers. Their ... to buy high quality hosting and save money ... of Top10BestSEOHosting.com says, “We believe that iPage and ... A lot of the global clients enjoy using ...
(Date:10/19/2014)... 20, 2014 Recently, Top10BestSEOHosting.com has ... that JustHost, GoDaddy and HostMonster are the best ... (Virtual Private Server) is the method of partitioning ... of which has the appearance and capabilities of ... why the site pays close attention to VPS ...
(Date:10/19/2014)... 2014 (HealthDay News) -- New stem cell-based research could ... new treatments, a new study suggests. Scientists used ... tissue in a lab dish. They then transplanted the ... intestinal disorders, according to the researchers. "This provides ... conditions that can cause intestinal failure, from genetic disorders ...
Breaking Medicine News(10 mins):Health News:Succeed Management Solutions, LLC Competes in Walking Challenge and Achieves 12th Place in Portland 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 3Health News:Top10BestSEOHosting.com Considers iPage And GreenGeeks As The Best Dedicated Server Hosting Suppliers 2Health News:The Best VPS Hosting Suppliers In The Market Unveiled By Top10BestSEOHosting.com 2Health News:Scientists Grow, Implant Human Intestinal Tissue in Mice 2
... 21 /Xinhua-PRNewswire/ -- Mindray Medical,International Limited (NYSE: ... medical devices worldwide announced today that it will ... from October,29 to November 1., Mindray will ... core product,segments: patient monitoring & life support products, ...
... -- Total revenues of $1.8 billion, up 3.4% -- ... -- Cash flow from operations improved to $329 million ... per diluted share -- Agreement in principle reached regarding ... N.J., Oct. 21 , 2008-- Quest,Diagnostics Incorporated (NYSE: DGX ...
... test has been developed to measure the effectiveness of Aspirin Therapy, based ... the benefits of taking aspirin on a daily basis. The Aspirin ... the patient, resulting in further prevention of heart attacks. , ... Los ...
... iPhone and iPod Touch, is released today worldwide. Simple spoken instructions ... Resuscitation or how to act when someone is choking. , ... ... an application for iPhone and iPod Touch, is released today worldwide. ...
... Sexual Health Foundation (TWSHF) released an issue of the Women,s Sexual ... the Foundation frequently addresses with healthcare professionals, cancer patients and survivors. ... discussed prior to or after their cancer treatment relating to intimacy ... ...
... Mexico at fraction of the US cost. Andy got several fillings ... sitting. Overseas Dentistry, including dental implants abroad cost a ... ... (PRWEB) October 21, 2008 -- Andy Gobienko was eating a burger the ...
Cached Medicine News:Health News:Mindray Medical to Exhibit New Products at 60th China International Medical Equipment Fair 2Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 2Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 3Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 4Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 5Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 6Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 7Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 8Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 9Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 10Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 11Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 12Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 13Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 14Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 15Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 16Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 17Health News:Breakthrough Testing for Patients on Aspirin Therapy for Preventing Heart Attacks 2Health News:Breakthrough Testing for Patients on Aspirin Therapy for Preventing Heart Attacks 3Health News:Save Lives with Your Mobile Phone - Doctor Releases First Aid Application for iPhone 2Health News:Intimacy and Sexuality After Cancer: Questions Answered and Concerns Addressed 2Health News:Intimacy and Sexuality After Cancer: Questions Answered and Concerns Addressed 3Health News:Intimacy and Sexuality After Cancer: Questions Answered and Concerns Addressed 4Health News:Dental Crown in Mexico -- Medical Tourism Corporation Assists US Teen with Huge Savings 2Health News:Dental Crown in Mexico -- Medical Tourism Corporation Assists US Teen with Huge Savings 3
The ACP 215 is the automated closed system cell processor with integrated process control....
... throughout the world are facing difficult times ... of the blood supply in the face ... donor base. Clearly, these centers must find ... manage their existing donor pools, and to ...
The Plasma Extractor is used to express blood components from collection containers. The spring-loaded front panel exerts pressure on the collection container causing the fluid to transfer until cont...
The Eppendorf Maxipettor is a continuously adjustable pipette for precise pipetting of volumes up to 10 ml (in 10 l increments). Even liquids with a high vapor pressure or viscosity can be pipetted w...
Medicine Products: